Partners Courtenay Brinckerhoff and Kristel Schorr contributed an article to Nature Reviews, “Patent Watch: Have the Biosimilar Floodgates Been Opened in the United States?” on April 30, 2015. The article discussed the first US Food and Drug Administration’s first approval of a biosimilar product and the regulatory hurdles products must clear before entering the US market.
